|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
|
GB2439393B
(en)
*
|
2006-06-23 |
2011-05-11 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB2450753B
(en)
*
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
ES2534900T3
(es)
|
2007-07-30 |
2015-04-30 |
Zynerba Pharmaceuticals, Inc. |
Profármacos de cannabidiol, composiciones que comprenden los profármacos de cannabidiol y métodos de uso de los mismos
|
|
GB2456183A
(en)
*
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
|
GB2471523A
(en)
*
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
US8445034B1
(en)
|
2010-11-02 |
2013-05-21 |
Albert L Coles, Jr. |
Systems and methods for producing organic cannabis tincture
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB2524689B
(en)
*
|
2011-05-20 |
2016-01-27 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
CA2895805A1
(en)
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
US10774288B2
(en)
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
GB2524469A
(en)
*
|
2014-02-14 |
2015-09-30 |
Kind Consumer Ltd |
A cannabinoid inhaler and composition therefor
|
|
US9918961B2
(en)
|
2014-02-19 |
2018-03-20 |
Kind Consumer Limited |
Cannabinoid inhaler and composition therefor
|
|
EP3134393B1
(en)
*
|
2014-04-21 |
2020-12-09 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Cyclohexenyl compounds, compositions comprising them and uses thereof
|
|
AU2015280412B2
(en)
|
2014-06-26 |
2018-07-26 |
Island Breeze Systems Ca, Llc |
MDI related products and methods of use
|
|
US9844518B2
(en)
|
2014-09-30 |
2017-12-19 |
MJAR Holdings, LLC |
Methods of growing cannabaceae plants using artificial lighting
|
|
WO2016092539A1
(en)
*
|
2014-12-07 |
2016-06-16 |
One World Cannabis Ltd |
Use of cannabis to treat migraine
|
|
CA2974292C
(en)
*
|
2015-01-31 |
2024-04-16 |
Constance Therapeutics, Inc. |
Methods for preparation of cannabis oil extracts and compositions
|
|
US20160298151A1
(en)
|
2015-04-09 |
2016-10-13 |
Sher Ali Butt |
Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products
|
|
HK1252151A1
(zh)
|
2015-05-28 |
2019-05-17 |
Tweed Inc. |
Thca合成酶表达改变的大麻植物
|
|
EP3380096A4
(en)
*
|
2015-11-24 |
2019-10-23 |
Constance Therapeutics, Inc. |
CANNABIS OIL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
|
|
EP3452036A4
(en)
|
2016-05-04 |
2019-11-06 |
Inmed Pharmaceuticals Inc. |
USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND ASSOCIATED BINDING WEB DISEASES
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
AU2017290107A1
(en)
|
2016-06-29 |
2019-01-17 |
CannScience Innovations Inc. |
Decarboxylated cannabis resins, uses thereof and methods of making same
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
SG11202001725SA
(en)
*
|
2017-09-01 |
2020-03-30 |
Pureform Global Inc |
Synthetic cannabidiol compositions and methods of making the same
|
|
SG11202002169TA
(en)
*
|
2017-09-15 |
2020-04-29 |
Zelda Therapeutics Operations Pty Ltd |
Composition and method for treating autism
|
|
EP3684353A4
(en)
*
|
2017-09-22 |
2021-06-23 |
Inmed Pharmaceuticals Inc. |
TOPICAL FORMULATIONS OF CANNABINOIDS AND THEIR USES FOR PAIN TREATMENT
|
|
US20190183849A1
(en)
*
|
2017-10-21 |
2019-06-20 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
JP2021506829A
(ja)
*
|
2017-12-20 |
2021-02-22 |
漢義生物科技（北京）有限公司 |
美白製品の調製におけるカンナビジオールまたは大麻抽出物の用途
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
GB201806953D0
(en)
*
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
SI25373A
(sl)
*
|
2018-05-08 |
2018-08-31 |
Danijela Marković |
Naravna orodisperzibilna tableta
|
|
CA3103504A1
(en)
*
|
2018-06-15 |
2019-12-19 |
CannPal Animal Therapeutics Limited |
Cannabinoid composition and methods of treatment using the same
|
|
WO2020051371A2
(en)
*
|
2018-09-05 |
2020-03-12 |
Noramco, Inc. |
Cannabidiol compositions having modified cannabinoid profiles
|
|
CA3119729A1
(en)
|
2018-10-10 |
2020-04-16 |
Treehouse Biotech, Inc. |
Synthesis of cannabigerol
|
|
WO2020220092A1
(en)
*
|
2019-05-01 |
2020-11-05 |
Cannadol Pharmaceuticals |
Compositions and methods for pain and anxiety relief
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
EP4037663A1
(en)
|
2019-10-03 |
2022-08-10 |
Starton Therapeutics, Inc. |
Transdermal delivery of dronabinol
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
US12186280B2
(en)
|
2019-10-11 |
2025-01-07 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
CN114555068A
(zh)
|
2019-10-14 |
2022-05-27 |
长矛治疗股份有限公司1219014 B.C.有限公司 |
大麻二酚的透皮给药
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
CA3160323A1
(en)
*
|
2019-11-07 |
2021-05-14 |
Amyris, Inc. |
Compositions and methods for delivering cannabinoids to skin
|
|
WO2022006187A1
(en)
*
|
2020-06-30 |
2022-01-06 |
Np Pharma Holdings, Llc |
Methods of using cannabinoid compositions for inducing and promoting sleep
|
|
CA3091622A1
(en)
|
2020-08-28 |
2022-02-28 |
Teresa Ann Hanlon |
Pain relieving formulations containing cannabis and methods of making same
|
|
WO2022159507A1
(en)
*
|
2021-01-19 |
2022-07-28 |
Merit Therapeutics, Inc. |
Combination of cannabinoids with additional therapeutic agents for treating diseases or disorders
|
|
WO2026033228A1
(en)
*
|
2024-08-08 |
2026-02-12 |
Curaleaf International Limited |
Formulation
|